FY2025 · period end Dec '25 · from the 10-K filed Feb 4, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
| Operating Income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B |
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $36.91B | $33.09B | $32.45B | $27.54B | — |
| Total Liabilities | $26.31B | $24.44B | $25.14B | $17.95B | — |
| Stockholders' Equity | $10.39B | $8.46B | $7.14B | $9.36B | $16.68B |
| Cash & Equivalents | $4.49B | $2.87B | $2.49B | $1.44B | — |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 15.9% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 12.8% |
| Return on Equity | 22.1% | 25.5% | 19.0% | 14.7% | 13.5% |
| Return on Assets | 6.0% | 6.1% | 5.2% | 7.0% | — |
| Debt / Equity | 1.01× | 1.23× | 1.32× | 0.88× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001932393-26-000046 | Jun 30, 2026 | Jul 29, 2026 | Jul 29, 2026 10:27 UTC | EDGAR |
| 10-Q | 0001932393-26-000031 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 10:26 UTC | EDGAR |
| 10-K | 0001932393-26-000007 | Dec 31, 2025 | Feb 4, 2026 | Feb 4, 2026 11:28 UTC | EDGAR |
| 10-Q | 0001932393-25-000053 | Sep 30, 2025 | Oct 29, 2025 | Oct 29, 2025 10:26 UTC | EDGAR |
| 10-Q | 0001932393-25-000049 | Jun 30, 2025 | Jul 30, 2025 | Jul 30, 2025 10:27 UTC | EDGAR |
| 10-Q | 0001932393-25-000014 | Mar 31, 2025 | Apr 30, 2025 | Apr 30, 2025 10:26 UTC | EDGAR |
| 10-K | 0001932393-25-000005 | Dec 31, 2024 | Feb 13, 2025 | Feb 13, 2025 11:26 UTC | EDGAR |
| 10-Q | 0001932393-24-000050 | Sep 30, 2024 | Oct 30, 2024 | Oct 30, 2024 10:32 UTC | EDGAR |
| 10-Q | 0001932393-24-000044 | Jun 30, 2024 | Jul 31, 2024 | Jul 31, 2024 10:26 UTC | EDGAR |
| 10-Q | 0001932393-24-000034 | Mar 31, 2024 | Apr 30, 2024 | Apr 30, 2024 10:27 UTC | EDGAR |
| 10-K | 0001932393-24-000013 | Dec 31, 2023 | Feb 6, 2024 | Feb 6, 2024 11:26 UTC | EDGAR |
| 10-Q | 0001932393-23-000125 | Sep 30, 2023 | Oct 31, 2023 | Oct 31, 2023 10:34 UTC | EDGAR |
Direct links to SEC EDGAR. GEHC has additional filings available on the SEC site.
6 numbers GE HealthCare Technologies Inc. later changed — same XBRL tag, both filings linked.
Increase (Decrease) in Accounts Payable·FY 2023
Major restatementwas-$13M
Revised down in a 10-K.
Deferred Tax Liabilities, Gross·As of Dec 31, 2023
Major restatementwas$50M
Revised up in a 10-K.
Increase (Decrease) in Accounts Payable·Q2 2024
Major restatementwas-$41M
Revised down in a 10-Q.
Increase (Decrease) in Accounts Payable·Q1 2024
Major restatementwas$81M
Revised down in a 10-Q.
Increase (Decrease) in Accounts Payable·FY 2024
Major restatementwas$126M
Revised down in a 10-K.
Restructuring Charges·FY 2023
Major restatementwas$54M
Revised down in a 10-K.
GEHC is not the only one.
See every restatement we've found across the market — or get an alert the next time GEHC revises a number.
Restatements are detected by comparing every vintage of a fact across all of GE HealthCare Technologies Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows GEHC's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling GE HealthCare Technologies Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on GEHC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on GEHC and publish the result to your public profile.
Ask about GE HealthCare Technologies Inc.
Continue in Workspace — cited answers on GEHC, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs